ischemia produces peripheral vascular dysfunction; the changes in LC phosphorylation and MYPT1 expression result in a decrease in both tone and the sensitivity to NO-mediated SM relaxation of the peripheral vasculature.
Introduction
The effects of acute ischemia on the ischemic vascular bed include decreases in vascular tone and the sensitivity of smooth muscle (SM) to nitric oxide (NO)-mediated vasodilatation [1, 2] . These changes in vascular reactivity occur within 30 min of ischemia and are thought to be mediated by an increase in the production of free radicals as well as interleukin-1 and tumor necrosis factor-␣ . Recurrent ischemia often leads to heart failure, which has been documented to be associated with an increase in peripheral vascular tone as well as a decrease in the sensitivity to NO-mediated vasodilatation [1] [2] [3] [4] . However, the effect of acute myocardial ischemia on the vasoreactivity of nonischemic peripheral vascular SM has not been investigated.
Contraction of SM is dependent on the level of phosphorylation of the 20-kDa regulatory SM myosin light chain (SM-LC), which is determined by the relative ac-tivities of myosin LC (MLC) kinase and MLC phosphatase [5] [6] [7] . However, recent evidence suggests that nonmuscle (NM) myosin also participates in the force maintenance phase of SM contraction and hence the regulation of vascular tone [5] [6] [7] [8] . In addition, NO-mediated vasodilatation is considered a fundamental response of the vasculature [9] , and changes in the sensitivity of NO-mediated SM relaxation are produced, in part, by an alteration in the expression of myosin phosphatase targeting subunit 1 (MYPT1) of MLC phosphatase [10, 11] , specifically by a decrease in the expression of the leucine zipper-positive (LZ+) MYPT1 isoform [11] [12] [13] .
This study was designed to determine the effect of 30 min of myocardial ischemia on the reactivity of tertiary (3rd) mesenteric arteries. Our data suggest that acute ischemia causes a dysregulation of SM and NM myosin, which results in a decrease in vascular tone and a reduction in the expression of MYPT1, which attenuates the sensitivity of NO-mediated vasodilatation.
Materials and Methods

Rat Acute Ischemia Model and Mesenteric Artery Preparation
The Institutional Animal Care and Use Committee of the Mayo Clinic approved all experimental protocols and animal care, and the study conforms to the guidelines of the National Institutes of Health. Our model of cardiac ischemia has been described in detail previously [14] [15] [16] ; briefly, adult male SpragueDawley rats (250-350 g) were injected intramuscularly with ketamine (60 mg/kg) and xylazine (12 mg/kg) and ventilated with room air. Animals were closely monitored for pain by testing the blink reflex. The heart was exposed by a midline thoracotomy, and a ligature was placed near the bifurcation of the left coronary artery, restricting flow through the left anterior descending and circumflex artery. Animals were divided into two experimental groups, i.e. one group with 30 min of perfusion (sham) and the other with 30 min of coronary occlusion (ischemia). Following either 30 min of perfusion or ischemia, mesenteric vessels were exteriorized, and mesenteric arteries were gently excised and transferred to a vessel chamber containing Ca 2+ -free Tyrode's solution (in m M : 135 NaCl, 4 KCl, 1 MgCl 2 , 0.33 Na 2 HPO 4 , 0.03 EDTA, 10 glucose, 10 HEPES; pH 7.4). Following careful removal of connective and adipose tissue, 3rd branches of the mesenteric artery were isolated.
Mechanical Studies
For force recordings, isolated 3rd mesenteric preparations (100-200 m in diameter, approx. 2 mm in length) with an intact endothelium were mounted using wires (40 m in diameter) on a DMT (Mulvany) 4-channel myograph system [17] [18] [19] (PE) . For one group of vessels, the force response to either KCl depolarization or PE was recorded for 10-15 min, before the vessel was relaxed. In a separate series of experiments, the vessels were depolarized, and after the force reached a steady state, the dose-response relationship of force relaxation produced by either acetylcholine (ACh) or the cellpermeable cGMP analog 8-bromo-cGMP (8-Br-cGMP) was determined.
SM and NM Myosin LC Phosphorylation
The time course of SM-LC and NM-LC phosphorylation in perfused versus ischemic mesenteric preparations was determined using 2-dimensional (2-D) gel electrophoresis [20] . We have demonstrated that this technique resolves the phosphorylated and nonphosphorylated NM-LCs and the phosphorylated and nonphosphorylated SM-LCs as four distinct spots [20] . The phosphorylation of NM-LC and SM-LC can then be determined using densitometry [20] . For these experiments, the vessels were activated with 80 m M KCl depolarization, and LC phosphorylation was determined at 0 (rest), 2 and 10 min of KCl depolarization. At the specified time, mesenteric microvessels were frozen in liquid nitrogen. As previously described [15, 20] , frozen tissues were homogenized in 2-D gel extraction buffer [7 M urea, 2 M thiourea, 4% CHAPS, 1% 3-5.6 immobilized pH gradient (IPG) buffer] and EDTA-free Complete Protease Inhibitor (Roche, Indianapolis, Ind., USA). The homogenates were cleared of lipids and extraneous salts using the 2-D gel clean-up kit (Amersham Biosciences, Piscataway, N.J., USA). The acidic halves of 13-cm IPG DryStrip gels (pH 3-5.6 nonlinear gradient) were rehydrated in the presence of suitable amounts of sample in rehydration buffer solution (7 M urea, 2 M thiourea, 2% CHAPS, 0.5% pH 3.5-5 IPG buffer, 0.002% bromophenol blue and 12 l/ml Destreak Reagent) for at least 10 h in the 'face-down' mode on the Ettan IPG rehydration tray and then resolved by isoelectric focusing in the 'face-up' mode on an Ettan IPGphor III (GE Healthcare). Following isoelectric focusing, the gel strips were equilibrated in 6 M urea, 50 m M Tris-HCL, pH 6.4, 30% glycerol, 2% (w/v) SDS and 0.002% bromophenol blue, first containing 130 m M DTT for 15 min and then containing 135 m M iodoacetamide for 15 min before undergoing SDS-PAGE for protein separation by molecular weight. Subsequently, resolved 2-D SDS-PAGE gels were silver stained. To measure the extent of SM-LC or NM-LC phosphorylation, stained gels were scanned using a Personal Densitometer SI, and the spots were quantified using ImageQuant TL software. The two spots closest to the anode represent the phosphorylated and nonphosphorylated NM-LC, and the two spots nearest the cathode represent the phosphorylated and nonphosphorylated SM-LC [20] . The NM-LC phosphorylation level is determined by the ratio of phosphorylated NM-LC to total NM-LC, and the SM-LC phosphorylation level is similarly calculated as the ratio of phosphorylated SM-LC to total SM-LC [20] .
Immunoblotting
Western blots were used to determine protein expression in perfused versus ischemic mesenteric preparations as previously described [10, 11, 13, 21] . Briefly, frozen total protein homogenates were suspended in SDS sample buffer. Proteins were resolved by SDS-PAGE using 8% gels with an acrylamide/bisacrylamide ratio of 29: 1. Following protein separation by SDS-PAGE, the proteins were transferred onto a polyvinylidene difluoride membrane. To detect MYPT1, LZ+ MYPT1, desmin and actin, a rabbit polyclonal anti-MYPT1 (Upstate Biotechnology), a mouse monoclonal anti-LZ+ MYPT1 isoform [10, 11] , a mouse monoclonal antidesmin (D1033, Sigma) and an anti-actin (A2066, Sigma) antibody were used. Following washing, the blots were incubated with Cy3-labeled antimouse IgG (Jackson Immunoresearch) or Cy5-labeled antirabbit IgG (GE Life Sciences). Blots were scanned on a Typhoon 9410 imager, and the scanned images were analyzed using ImageQuant TL software. For all sample preparations, the quantified signal for the protein of interest was divided by the ␤ -actin signal to provide an internally controlled value of the relative expression. To normalize values across different blots, one of the sample preparations was chosen as a standard sample and loaded on all Western blots.
Protein polyubiquitination was assessed using immunoblotting with a mouse monoclonal antibody [Ub (P4D1), Santa Cruz Biotechnology], and ubiquitination was quantified with densitometry and normalized to actin, as described above.
Statistical Analysis
All data are presented as means 8 SEM, and n represents the number of animals in each group. Student's t test was performed to evaluate significant differences between the two groups, and differences were considered to be significant at p ! 0.05. When multiple comparisons between groups were necessary, a Bonferroni correction was performed.
Results
Following KCl depolarization, force rapidly rose to a peak in both perfused and ischemic preparations (16.8 8 2.2 vs. 16.3 8 2.1 mN; n = 6; p 1 0.05). In perfused preparations, force slowly declined to 78.6 8 3.1% (n = 6) of the peak force during force maintenance ( fig. 1 a) . In contrast, for the ischemic 3rd mesenteric arterial vessels, the ability to maintain force was significantly compromised ( fig. 1 a) ; force maintenance was 70.6 8 1.1% of peak force (n = 6; p ! 0.05 vs. perfused). With PE stimulation, force also rose to a peak in perfused and ischemic preparations [13.8 8 1.1 mN (n = 5) vs. 12.5 8 1.5 mN (n = 4); p 1 0.05]. In perfused preparations, force remained at a steady state (97.8 8 1.2% of peak; p 1 0.05), while in ischemic preparations, force fell by approximately 30% to 72.3 8 6.5% of peak force (p ! 0.05) during force maintenance ( fig. 1 b) .
The expression of NM myosin was similar in perfused and ischemic 3rd mesenteric vessels (7.8 8 1.9 vs. 10.8 8 2.4%; n = 6; p 1 0.05). Thus, to explore the mechanism underlying the ischemia-induced decline in force maintenance, we determined the time course of SM-LC and NM-LC phosphorylation. For depolarization of perfused Following KCl depolarization, force rapidly rises to a peak in both perfused and ischemic preparations. However, force maintenance was reduced in the ischemic mesenteric vessels compared to that in perfused vessels (p ! 0.05). b Representative force tracings of perfused (black line) and ischemic (gray line) mesenteric microvessels during PE activation. Force rapidly rises to a peak in both perfused and ischemic preparations. However, force maintenance was reduced in the ischemic mesenteric vessels compared to that in perfused vessels (p ! 0.05).
preparations, SM-LC phosphorylation did not change, but there was a significant increase in NM-LC phosphorylation (7.8 8 1.9% at rest vs. 16.6 8 3.5% at 2 min; p ! 0.05; n = 5; fig. 2 ), suggesting that in 3rd mesenteric vessels both force activation and maintenance are regulated by the activation of NM myosin. For depolarization of ischemic preparations, there was no detectable NM-LC phosphorylation. Resting SM-LC phosphorylation compared to perfused was significantly lower, and depolarization resulted in a significant increase in SM-LC phosphorylation (6.7 8 1.4% at rest vs. 12.5 8 1.7% at 2 min; p ! 0.05; n = 5; fig. 2 ). These data suggest that following myocardial ischemia, force activation and maintenance are dependent on the activation of SM myosin, and ischemia results in a change in the activation (phosphorylation) of both SM and NM myosin.
We investigated NO-mediated signaling by determining the dose-response relationship of ACh-induced relaxation of 3rd mesenteric arteries. For the perfused and ischemic preparations, ACh produced a dose-dependent relaxation ( fig. 3 a) . For perfused versus ischemic vessels, there was no significant difference in the sensitivity to ACh (median effective dose 100 8 8 vs. 97 8 4 n M ; p 1 0.05; n = 5). However, ACh produced a significantly larger maximal relaxation in the perfused 3rd mesenteric vessels (56 8 6 vs. 38 8 4%; p ! 0.05; n = 5; fig. 3 a) . To determine whether the impairment of ACh-mediated SM relaxation in ischemic mesenteric vessels was due to a defect at the level of the SM contractile apparatus, similar experiments were performed using 8-Br-cGMP ( fig. 3 b) ; similar to ACh-mediated relaxation, there was no difference in the sensitivity to 8-Br-cGMP (median effective We have previously demonstrated that a decrease in the sensitivity to cGMP-mediated SM relaxation is produced by a decrease in the expression of the LZ+ MYPT1 isoform [10, 11] . Thus, Western blots were used to evaluate MYPT1 and LZ+ MYPT1 expression in perfused and ischemic mesenteric vessels ( fig. 4 ) , and the expression of both MYPT1 and LZ+ MYPT1 in ischemic mesenteric vessels was significantly depressed when compared to perfused vessels (MYPT1: 64 8 8%, p ! 0.05, n = 4; LZ+ MYPT1: 74 8 6%, p ! 0.05, n = 4; fig. 4 ). We also examined Coomassie staining of SDS gels and noted that there was a significant difference in the density of two protein bands comparing perfused and ischemic vessels ( fig. 5 ) , at approximately 25 kDa and approximately 60 kDa. We identified these proteins using mass spectrometry; the 25-kDa protein is SM-22 ␣ , while the 60-kDa protein(s) is either ATP synthase, adenylyl cyclase, glutamate dehydrogenase and/or desmin. The expression of SM-22 ␣ decreased during depolarization (66 8 3% of perfused at 10 min; p ! 0.05; n = 4). Desmin expression was similar in perfused and ischemic vessels (online suppl. fig. S1 ; for all online suppl. material, see www.karger.com/doi/10.1159/000343015), and thus, the identity and significance of the protein(s) at approximately 60 kDa with lower expression in the ischemic preparations will require further study.
To investigate if the decline in protein expression could be due to degradation by a ubiquitin-proteasome system, we examined the extent of protein polyubiquitination with immunoblotting. A significant increase in protein polyubiquitination was observed in the ischemic compared to perfused mesenteric vessels (p ! 0.05; online suppl. fig. S2 ).
Discussion
The effect of acute myocardial ischemia on the vasoreactivity of the coronary vessels has been documented [1, 2] , but the effect of myocardial ischemia on the reactivity of noncardiac resistance microvessels has not been investigated. Therefore, the main objective of this study was to investigate the effect of acute ischemia on the vascular function of nonischemic resistance vessels. In the present study, we found that acute myocardial ischemia produced dysfunction in 3rd mesenteric vessels, which was characterized by a decrease in force maintenance for both KCl and PE stimulation and also a decrease in NO-mediated SM relaxation.
Force Maintenance
Recent evidence suggests that NM myosin participates in the force maintenance phase of SM contraction and the regulation of vascular tone [20, [22] [23] [24] [25] ; we have reported that a 50% reduction in the expression of NM myosin in the rat aorta was associated with a 25% decrease in force maintenance [20] . In 3rd mesenteric vessels, NM myosin expression is approximately 10% of total myosin heavy chain, similar to NM myosin expression in rat aorta [20] . In perfused preparations, KCl depolarization resulted in a sustained increase in phosphorylation of NM-LC but not of SM-LC ( fig. 2 ). These data suggest that NM myosin participates in the regulation of force and vascular tone in 3rd mesenteric vessels. Thus, a change in the phosphorylation of NM myosin in ischemic vessels would be expected to decrease force maintenance. Following 30 min of myocardial ischemia, there was no detectable phosphorylation of NM-LC. However, KCl depolarization produced a significant increase in SM-LC phosphorylation ( fig. 2 ). These results demonstrate that ischemia changes the mechanism for force regulation in 3rd mesenteric arteries; ischemia produces a shift from a dependence on the activation of NM myosin to SM myosin. Thus, as proposed by others [8, 26, 27 ] , our data demonstrate that the activation of NM myosin is important for force maintenance. The magnitude of the change in the phosphorylation of the LCs in the mesenteric vessels was approximately 6-8% ( fig. 2 ) . In resistance vessels, pressurization has been demonstrated to be important for the absolute magnitude of LC phosphorylation [28] , and in the present study, it is possible that the changes in both NM-LC and SM-LC phosphorylation would have been larger if the vessels had been pressurized. Further, following depolarization, force peaks at 30-60 s, which would suggest that LC phosphorylation would be at a maximum earlier than the 2-min time point measured in our study. However, force activation during PE stimulation and depolarization of rabbit urethral SM is regulated by a Rho kinase-dependent pathway, but with no detectable change in LC phosphorylation [29] . The NM-LC and SM-LC differ by only 9 amino acids, and the anti-SM-LC antibody detects both SM-LC and NM-LC [20] . A Rho kinase-mediated pathway has been demonstrated to activate NM myosin [20] , and thus for urethral SM, an increase in NM-LC phosphorylation may have been detected using 2-D SDS-PAGE.
NO-Mediated SM Relaxation
Others have demonstrated that ischemia produces endothelial dysfunction of the ischemic vascular bed [1, 2] . NO signaling causes SM relaxation using both Ca 2+ -dependent and Ca 2+ -independent (Ca 2+ desensitization) mechanisms [30] [31] [32] . During NO stimulation, NO diffuses into the SM cell to activate guanylate cyclase, which increases cGMP, subsequently activating protein kinase G. Protein kinase G mediates phosphorylation of a number of targets to produce a reduction in intracellular Ca 2+ , leading to a Ca 2+ -dependent relaxation, but it also activates MLC phosphatase to produce Ca 2+ desensitization. Our data demonstrate that myocardial ischemia produces a decrease in the relaxation of 3rd mesenteric vessels produced by both ACh and 8- Br-cGMP ( fig. 3 ) . We have demonstrated that a decrease in LZ+ MYPT1 expression produces a reduction in cGMP-mediated SM relaxation [10, 11] , and a decrease in both LZ+ MYPT1 expression and cGMP-mediated SM relaxation has been documented in nitrate tolerance [33, 34] and heart failure [12, 35] as well as other vascular diseases [36] . Similarly, our data demonstrate that myocardial ischemia produces a decrease in the expression of both MYPT1 and the LZ+ MYPT1 isoform in 3rd mesenteric vessels ( fig. 4 ) . Although myocardial ischemia could produce endothelial dysfunction and a decrease in NO, these data demonstrate a defect at the level of the SM specifically; the decrease in MYPT1 expression contributes to the molecular mechanism responsible for the reduction in the relaxation of the mesenteric vessels by NO-based vasodilators.
The ischemia-induced decrease in MYPT1 expression ( fig. 4 ) could suggest that acute ischemia triggers calpaininduced proteolysis or ubiquitin-proteasome-based degradation. During depolarization with 80 m M KCl, the intracellular Ca 2+ concentration increases to a sustained steady state [37] , which could suggest that the decrease in MYPT1 expression is due to a Ca 2+ -dependent process, such as calpain. However, calpain degradation produces large fragments of the intact protein [38] , which we did not observe ( fig. 5 ). Ubiquitin covalently attaches to proteins that are subsequently delivered to the proteasome for rapid degradation. The 26S proteasome is responsible for the degradation of polyubiquitinated proteins [39] and is expressed in vascular SM [40, 41] . The 26S proteasome is composed of a 20S catalytic core and two 19S regulatory particles [39] . The 20S core is composed of 2 ␣ rings ( ␣ 1-7) and 2 ␤ rings ( ␤ 1-7); the ␣ rings bind proteasome regulators and identify ubiquitinated proteins targeted for degradation [39, 42] , and the ␤ rings contain catalytically active sites [39, 42] . Thus, an increase in polyubiquitinated protein complexes (online suppl. fig. S2 ) could suggest that the decrease in protein expression is due to protein degradation by the ubiquitin-proteasome pathway.
In addition to MYPT1, the expression of SM-22 ␣ was lower in the ischemic preparations ( fig. 5 ). SM-22 ␣ [43] is abundant in SM; SM-22 ␣ is a cytoskeletal protein that binds to actin filaments at a ratio of 1: 6 actin monomers and has been suggested to regulate the organization of thin filaments within the cytoskeleton of the SM cell [44] . SM-22 ␣ -deficient mice have no phenotype, although SM tissue mechanics have not been reported [43] . Ali et al. [45] have suggested that both actin and myosin filaments reorganize (shorten) in response to changes in SM length. Thus, one possible explanation for the decrease in SM-22 ␣ in the ischemic preparations is that depolarization of the ischemic mesenteric vessel results in an actin filament depolymerization/repolymerization, which shortens the overall thin filament length, resulting in free, unbound SM-22 ␣ that is subsequently targeted for degradation or proteolysis.
The mechanism and/or signaling responsible for triggering the changes in remote, nonischemic vascular beds are unclear. Although we did not measure hemodynamics during the coronary ligation, studies establishing these parameters during acute coronary ischemia have been published for animals [46, 47] and humans [48] . These investigators have demonstrated that there is no significant change in either blood pressure or heart rate during 30 min of coronary artery ligation in dogs [46] or rats [47] . It is unlikely that production of free radicals in the coronary beds would result in a significant elevation in 3rd mesenteric arteries. The decrease in cardiac output during 30 min of ischemia could decrease the partial pressure of oxygen and increase the partial pressure of carbon dioxide in the mesenteric beds, which could increase the production of free radicals. However, we would expect free radical modification to be more widespread rather than limited to only MYPT1 and SM-22 ␣ . Further, changes in MYPT1 isoform expression have also been documented during development [49, 50] , as well as in animal models of portal hypertension [51] and pregnancy-induced hypertension [52] ; these investigators [51, 52] suggested that changes in pressure and flow regulate MYPT1 isoform expression. Nonetheless, the trigger for the changes in protein expression during ischemia will require further investigation.
Conclusion
Our data demonstrate that acute myocardial ischemia decreases force maintenance in 3rd mesenteric vessels stimulated to contract with either KCl, which leads to an increase in intracellular Ca 2+ , or PE, which increases Ca 2+ and also activates signaling pathways for Ca 2+ sensitization. Further, acute myocardial ischemia (1) changes the regulation of force from requiring the activation of NM myosin to activation of SM myosin, which results in an impairment in force maintenance, and (2) decreases the expression of both MYPT1 and the LZ+ MYPT1 isoform, which produces a reduction in the relaxation of 3rd mesenteric vessels in response to NO-based vasodilators. These findings demonstrate that even acute myocardial dysfunction results in vascular dysfunction and in changes of the reactivity of the peripheral vasculature. Further, our results demonstrate that the activation of NM myosin participates in the regulation of vascular tone, and identifying the mechanism underlying the changes in the activation of NM/SM myosin and the expression of MYPT1 will provide insight into the development of therapeutic strategies for myocardial ischemia.
